Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Key FDA Decisions and Trial Results Expected in October
Key FDA Decisions and Trial Results Expected in October
Key FDA Decisions and Trial Results Expected in October
Submitted by
admin
on October 4, 2016 - 10:07am
Source:
24/7 Wall St
News Tags:
FDA
clinical trials
Exelixis
cabozantinib
Cobimetinib
Celldex Therapeutics
CDX-011
Cerulean Pharma
CRLX101
Medivation
Xtandi
Palatin
bermelanotide
Rexahn
RX-3117
Anthera Pharmaceuticals
Headline:
Key FDA Decisions and Trial Results Expected in October
Do Not Allow Advertisers to Use My Personal information
